Human breast cancer tissue expresses high level of type 1 5′-deiodinase

Thyroid

Volumn 17, Issue 1, 2007, Pages 3-10

  Debski, Marcin Grzegorz ^a   Pachucki, Janusz ^a   Ambroziak, Michal ^b   Olszewski, Wlodzimierz ^c   Bar Andziak, Ewa ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MESSENGER RNA; THYROXINE; THYROXINE DEIODINASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; ENERGY EXPENDITURE; ENZYME ACTIVITY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LUNG CANCER; MASTECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL DIFFERENTIATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IODIDE PEROXIDASE; MIDDLE AGED; NEOPLASM STAGING; RNA, MESSENGER; THYROID GLAND; TRIIODOTHYRONINE;

EID: 33846820410     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0012     Document Type: Article

References (47)

1. Malm J 2004 Thyroid hormone ligands and metabolic diseases. Curr Pharm Des 10:3525-3532.
2. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89.
3. Aceves C, Valverde C 1989 Type I, ′-monodeiodinase activity in the lactating mammary gland. Endocrinology 124:2818-2820.
4. Aceves C, Rojas-Huidobro R 2001 Effect of suckling and adrenergic stimulation on peripheral deiodination in lactating rats: differential expression of type 1 deiodinase mRNA forms. J Endocrinol 171:533-540.
5. Aceves C, Pineda O, Ramirez I, de la Luz Navarro M, Valverde C 1999 Mammary type I deiodinase is dependent on the suckling stimulus: differential role of norepinephrine and prolactin. Endocrinology 140:2948-2953.
6. Navarro L, Landa A, Valverde RC, Aceves C 1997 Mammary gland type I iodothyronine deiodinase is encoded by a short messenger ribonucleic acid. Endocrinology 138:4248-4254.
7. Macejova D, Liska J, Brtko J 2001 Mammary gland carcinoma-related increase of type I iodothyronine 5′-deiodinase activity in Sprague-Dawley rats. Gen Physiol Biophys 20:293-302.
8. Pachucki J, Ambroziak M, Tanski Z, Luczak J, Nauman J, Nauman A 2001 Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. J Endocrinol Invest 24:253-261.
9. Ambroziak M, Pachucki J, Stachlewska-Nasfeter E, Nauman J, Nauman A 2005 Disturbed expression of type 1 and type 2 iodothyronine deiodinase as well as titf1/nkx2-1 and pax-8 transcription factor genes in papillary thyroid cancer. Thyroid 15:1137-1146.
10. Arnaldi LA, Borra RC, Maciel RM, Cerutti JM 2005 Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors. Thyroid 15:210-221.
11. Schreck R, Schnieders F, Schmutzler C, Kohrle J 1994 Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines. J Clin Endocrinol Metab 79:791-798.
12. Wawrzynska L, Sakowicz A, Rudzinski P, Langfort R, Kurzyna M 2003 The conversion of thyroxine to triiodothyronine in the lung: comparison of activity of type I iodothyronine 5′ deiodinase in lung cancer with peripheral lung tissues. Monaldi Arch Chest Dis 59:140-145.
13. Baur A, Buchfelder M, Kohrle J 2002 Expression of 5′-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas. Eur J Endocrinol 147:263-268.
14. de Souza Meyer EL, Dora JM, Wagner MS, Maia AL 2005 Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentiation towards papillary carcinoma. Clin Endocrinol (Oxf) 62:672-678.
15. Ali IU, Lidereau R, Callahan R 1989 Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma. J Natl Cancer Inst 81:1815-1820.
16. Futreal PA, Soderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW 1992 Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52:2624-2627.
17. Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A 2003 Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 192:121-132.
18. Silva JM, Dominguez G, Gonzalez-Sancho JM, Garcia JM, Silva J, Garcia-Andrade C, Navarro A, Munoz A, Bonilla F 2002 Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 21:4307-4316.
19. Vasudevan N, Ogawa S, Pfaff D 2002 Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. Physiol Rev 82:923-944.
20. Takatani O, Okumoto T, Kosano H, Nishida M, Hiraide H, Tamakuma S 1989 Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women. Cancer Res 49:3109-3112.
21. Thomas BS, Bulbrook RD, Russell MJ, Hayward JL, Millis R 1983 Thyroid function in early breast cancer. Eur J Cancer Clin Oncol 19:1213-1219.
22. Yokoe T, Lino Y, Takei H, Horiguchi J, Koibuchi Y, Maemura M, Ohwada S, Morishita Y 1997 Changes of cytokines and thyroid function in patients with recurrent breast cancer. Anticancer Res 17:695-699.
23. Murai H, Murakami S, Ishida K, Sugawara M 1996 Elevated serum interleukin-6 and decreased thyroid hormone levels in postoperative patients and effects of IL-6 on thyroid cell function in vitro. Thyroid 6:601-606.
24. Zumoff B, O'Connor J, Levin J, Markham M, Strain GW, Fukushima DK 1981 Plasma levels of thyroxine and triiodothyronine in women with breast cancer. Anticancer Res 1:287-291.
25. Lemaire M, Baugnet-Mahieu L 1986 Thyroid function in women with breast cancer. Eur J Cancer Clin Oncol 22:301-307.
26. Nogueira CR, Brentani MM 1996 Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol 59:271-279.
27. Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak WE, Jr., Mazzaferri EL, Jhiang SM 2000 Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936-2943.
28. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N 2000 The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871-878.
29. Tanosaki S, Ikezoe T, Heaney A, Said JW, Dan K, Akashi M, Koeffler HP 2003 Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. Breast Cancer Res Treat 79:335-345.
30. World Health Organization Classification of Tumours 2003 Tumours of the breast and female genital organs. In: Tavassoli FA, Devilee P (eds) Pathology & Genetics. Lyon, France, pp 10-12.
31. Chomczynski P 1993 A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-534, 536-537.
32. Garcia-Solis P, Aceves C 2003 5′Deiodinase in two breast cancer cell lines: effect of triiodothyronine, isoproterenol and retinoids. Mol Cell Endocrinol 201:25-31
33. Wiseman BS, Werb Z 2002 Stromal effects on mammary gland development and breast cancer. Science 296:1046-1049.
34. Schomburg L, Schweizer U, Kohrle J 2004 Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 61:1988-1995.
35. Jakobs TC, Mentrup B, Schmutzler C, Dreher I, Kohrle J 2002 Proinflammatory cytokines inhibit the expression and function of human type I 5′-deiodinase in HepG2 hepatocarcinoma cells. Eur J Endocrinol 146:559-566.
36. Yu J, Koenig RJ 2000 Regulation of hepatocyte thyroxine 5′-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem 275:38296-38301.
37. Kim SW, Hong SJ, Kim KM, Ho SC, So EC, Harney JW, Larsen PR 2004 A novel cell type-specific mechanism for thyroid hormone-dependent negative regulation of the human type 1 deiodinase gene. Mol Endocrinol 18:2924-2936.
38. Brtko J, Bobalova J, Podoba J, Schmutzler C, Kohrle J 2002 Thyroid hormone receptors and type I iodothyronine 5′-deiodinase activity of human thyroid toxic adenomas and benign cold nodules. Exp Clin Endocrinol Diabetes 110:166-170.
39. Zhang CY, Kim S, Harney JW, Larsen PR 1998 Further characterization of thyroid hormone response elements in the human type 1 iodothyronine deiodinase gene. Endocrinology 139:1156-1163.
40. Amma LL, Campos-Barros A, Wang Z, Vennstrom B, Forrest D 2001 Distinct tissue-specific roles for thyroid hormone receptors beta and alpha 1 in regulation of type 1 deiodinase expression. Mol Endocrinol 15:467-475.
41. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH 1992 Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol 6:429-442.
42. Ikeda M, Rhee M, Chin WW 1994 Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements. Endocrinology 135:1628-1638.
43. Vasudevan N, Koibuchi N, Chin WW, Pfaff DW 2001 Differential crosstalk between estrogen receptor (ER)alpha and ERbeta and the thyroid hormone receptor isoforms results in flexible regulation of the consensus ERE. Brain Res Mol Brain Res 95:9-17.
44. Berry MJ, Banu L, Larsen PR 1991 Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349:438-440.
45. Strain JJ, Bokje E, van't Veer P, Coulter J, Stewart C, Logan H, Odling-Smee W, Spence RA, Steele K 1997 Thyroid hormones and selenium status in breast cancer. Nutr Cancer 27:48-52.
46. Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L 2003 Selenium in breast cancer. Oncology 64:227-231.
47. Sabatino L, Iervasi G, Ferrazzi P, Francesconi D, Chopra IJ 2000 A study of iodothyronine 5′-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues. Life Sci 68:191-202.